Both in Pharmaceuticals
Janux Therapeutics vs Latigo Biotherapeutics
Over the past year JANX returned +2.9% and LTGO returned −28.5%; their daily moves had a correlation of 0.08.
JANX +2.9% LTGO −28.5%Growth of $1, one year, split-adjusted
| Metric | JANX | LTGO |
|---|---|---|
| Price | $17.60 | $15.83 |
| Market cap | $1.08B | $1.05B |
| Today | +1.97% | +4.08% |
| 1 month | +3.8% | −12.5% |
| 6 months | +24.7% | — |
| Year to date | +27.5% | — |
| 1 year | −35.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −214.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 44.8× | — |
| Net cash | $970.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 47.2% | — |
| Short % of float | 11.8% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).